| In Vitro Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth–Throat Models and In Vitro—In Vivo Correlations for a Dry Powder Inhaler, Metered … X Wei, M Hindle, A Kaviratna, BK Huynh, RR Delvadia, D Sandell, ... Journal of aerosol medicine and pulmonary drug delivery 31 (6), 358-371, 2018 | 71 | 2018 |
| Delivery and performance of surfactant replacement therapies to treat pulmonary disorders N El-Gendy, A Kaviratna, C Berkland, P Dhar Therapeutic Delivery 4 (8), 951-980, 2013 | 49 | 2013 |
| Dynamic measurements of membrane insertion potential of synthetic cell penetrating peptides NA Alhakamy, A Kaviratna, CJ Berkland, P Dhar Langmuir 29 (49), 15336-15349, 2013 | 27 | 2013 |
| Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth RL Walenga, PW Longest, A Kaviratna, M Hindle Journal of Aerosol Medicine and Pulmonary Drug Delivery 30 (3), 190-205, 2017 | 26 | 2017 |
| Proapoptotic lipid nanovesicles: Synergism with paclitaxel in human lung adenocarcinoma A549 cells N Joshi, T Shanmugam, A Kaviratna, R Banerjee Journal of controlled release 156 (3), 413-420, 2011 | 25 | 2011 |
| The effect of acids on dipalmitoyl phosphatidylcholine (DPPC) monolayers and liposomes AS Kaviratna, R Banerjee Colloids and Surfaces A: Physicochemical and Engineering Aspects 345 (1-3 …, 2009 | 24 | 2009 |
| Evaluation of bio-relevant mouth-throat models for characterization of metered dose inhalers A Kaviratna, G Tian, X Liu, R Delvadia, S Lee, C Guo AAPS PharmSciTech 20, 1-9, 2019 | 21 | 2019 |
| Nanovesicle aerosols as surfactant therapy in lung injury AS Kaviratna, R Banerjee Nanomedicine: Nanotechnology, Biology and Medicine 8 (5), 665-672, 2012 | 21 | 2012 |
| Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective B Newman Advanced Drug Delivery Reviews 190, 114526, 2022 | 13 | 2022 |
| Multi trigger responsive, surface active lipid nanovesicle aerosols for improved efficacy of paclitaxel in lung cancer N Joshi, A Kaviratna, R Banerjee Integrative biology 5 (1), 239-248, 2013 | 13 | 2013 |
| Aerosol delivery of paclitaxel-containing self-assembled nanocochleates for treating pulmonary metastasis: An approach supporting pulmonary mechanics T Shanmugam, N Joshi, A Kaviratna, N Ahamad, E Bhatia, R Banerjee ACS Biomaterials Science & Engineering 7 (1), 144-156, 2020 | 10 | 2020 |
| Effect of meconium on surface properties of surfactant monolayers and liposomes V Pallem, AS Kaviratna, G Chimote, R Banerjee Colloids and Surfaces A: Physicochemical and Engineering Aspects 370 (1-3), 6-14, 2010 | 8 | 2010 |
| Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective N El-Gendy Advanced Drug Delivery Reviews 189, 114519, 2022 | 7 | 2022 |
| Advancements in the design and development of dry powder inhalers and potential implications for generic development AR Mohan, Q Wang, S Dhapare, E Bielski, A Kaviratna, L Han, S Boc, ... Pharmaceutics 14 (11), 2495, 2022 | 6 | 2022 |
| Pulmonary Surfactant Nanostructures and their Implications A Kaviratna, A Shah, SS Rao, R Banerjee Dynamic Biochemistry, Process Biotechnology and Molecular Biology 3 (2), 21-32, 2009 | 4 | 2009 |
| Protein free surfactant composition for pulmonary diseases and a process for preparing the same R Banerjee, A Kaviratna US Patent 9,345,716, 2016 | 3 | 2016 |
| Characterization of spray dried azithromycin dry powders for inhalation M Hindle, A Kaviratna, D Yamarthi, P Longest JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 28 (4), A9-A9, 2015 | 3 | 2015 |
| Evaluation of bio-relevant mouth-throat (MT) models to determine the aerosol deposition and particle size distribution of QVAR® using cascade impactor A Kaviratna, X Liu, R Delvadia, C Guo American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, 2016 | 1 | 2016 |
| Vesicular lipid nanoparticles (liposomes) for the treatment of medical device infections E Taylor, A Kaviratna, R Banerjee, TJ Webster MRS Online Proceedings Library (OPL) 1316, mrsf10-1316-qq12-23, 2011 | 1 | 2011 |
| Aerosol Performance and Stability Characteristics of Spray-dried Tobramycin Excipient Enhanced Growth Inhalation Powder Formulations X Wei, A Kaviratna, R Darweesh, PW Longest, M Hindle Journal of Aerosol Medicine and Pulmonary Drug Delivery 30 (4), A8-A8, 2017 | | 2017 |
